News Meeting of the American College of Cardiology in New Orleans, 7-10 March

Benefits of implantable cardiac defibrillators in heart failure are confirmed

BMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7441.664-a (Published 18 March 2004) Cite this as: BMJ 2004;328:664
  1. Janice Hopkins Tanne
  1. New York

    Implantable cardiac defibrillators significantly reduce mortality in patients with heart failure and impaired left ventricular function, a new study shows.

    Dr Gust Bardy of the Seattle Institute for Cardiac Research, Washington, reported the study to the conference.

    The sudden cardiac death in heart failure trial (SCD-HeFT) was a randomised controlled trial of an implantable cardiac defibrillator in addition to standard treatment. It reduced mortality by 23% in a five year study of 2521 patients at …

    View Full Text

    Sign in

    Log in through your institution

    Subscribe